Mirus Bio
Manufacturing · Wisconsin, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5602 Research Park Blvd Ste 210, Madison...Phone Number
(608) 441-2852Website
www.mirusbio.comRevenue
$11 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Mirus Bio
Founded in 1995 and headquartered in Madison, WI, Mirus Bio is a leading provider of transfection products for the biopharmaceutical and research industries, offering best-in-class reagents for gene therapy, recombinant protein, and stem cell applications. An original pioneer in nucleic acid delivery, the company has been enabling scientific research and innovation for more than two decades. In 2021, Mirus introduced TransIT-VirusGEN® GMP Transfection Reagent and Enhancers to address the commercial biopharmaceutical and cell and gene therapy markets with support for virus manufacturing, gene editing and biotherapeutic protein production.Explore more
Mirus Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mirus Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Mirus Bio has new funding data
Product Launch: Get notified when Mirus Bio launches new products
Earning: See what the market has to say on Mirus Bio recently announced quarterly report
Mirus Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mirus Bio
Website visits: Recent activity has been detected on your website
Check out if Mirus Bio is spiking on competitors!
Check if Mirus Bio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Mirus Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Mirus Bio
Find 3 more new buyers
Compare Similar Companies to Mirus Bio
Compare insights from companies similar to Mirus Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mirus Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mirus Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mirus Bio.
Mirus Bio financials insights
Gather financial insights about Mirus Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$543K
Mirus Bio Tech Stack
A closer look at the technologies used by Mirus Bio
Most Recent Scoops
Promotion
Executive Move
Mirus Bio has announced that Geoffrey Schwartz has been promoted from Chief Executive Officer to the role of Chief Executive Officer & General Manager.
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
New Hire
Executive Move
Scott Hinkelman has joined the organization as Director, Finance.
Executive Moves, New Hire
Open Position
Mirus Bio is currently seeking a Director Of Business Development. (Madison, WI)
New Hire
Executive Move
Mirus Bio News & Media
MilliporeSigma boosts its gene therapy manufacturing capability with $600 M acquisition of Mirus Bio
MilliporeSigma, the Massachusetts-based contract manufacturing arm of Merck KGaA, is increasing its presence in the gene therapy manufacturing field as it hasGamma Biosciences Announces Sale of Mirus Bio to Merck KGaA, Darmstadt, Germany, for $600 Million
MENLO PARK, Calif. and MADISON, Wis., May 23, 2024 /PRNewswire/ -- Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, today announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany (XTRA:MRK), a...MIRUS BIO NAMED A TOP WORKPLACE BY THE WISCONSIN STATE JOURNAL
MADISON, Wis., March 26, 2024 /PRNewswire/ -- Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical manufacturing, and discovery applications, has been named a Top Workplace 2024 by...Mirus Bio Receives ISO 13485:2016 Certification
Completion of this comprehensive certification process underscores the quality of the processes used to support the company's GMP product portfolio MADISON, Wis., Jan. 31, 2024 /PRNewswire/ -- Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mirus Bio
Sign Up For FreeTo access detailed company insights
Founded in 1995 and headquartered in Madison, WI, Mirus Bio is a leading provider of transfection products for the biopharmaceutical and research industries, offering best-in-class reagents for gene therapy, recombinant protein, and stem cell applications. An original pioneer in nucleic acid delivery, the company has been enabling scientific resear... Read More
